Ainos, Inc. Files 10-Q for Q1 2025
Ticker: AIMDW · Form: 10-Q · Filed: May 14, 2025 · CIK: 1014763
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Ainos Inc. 10-Q filed. Q1 2025 update.
AI Summary
Ainos, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly Amarillo Biosciences Inc., is in the pharmaceutical preparations industry and is incorporated in Texas. Its business and mailing address are in San Diego, California.
Why It Matters
This filing provides an update on Ainos, Inc.'s financial performance and operational status for the first quarter of 2025, which is crucial for investors to assess the company's trajectory.
Risk Assessment
Risk Level: low — This filing is a standard quarterly report and does not contain immediate, high-impact news.
Key Numbers
- 20250331 — Period End Date (The report covers the financial performance up to this date.)
- 20250514 — Filing Date (The date the report was officially submitted to the SEC.)
Key Players & Entities
- Ainos, Inc. (company) — Filer
- Amarillo Biosciences Inc. (company) — Former company name
- 20250331 (date) — Period of report
- 20250514 (date) — Filing date
FAQ
What is the primary business of Ainos, Inc.?
Ainos, Inc. is in the Pharmaceutical Preparations industry, with SIC code 2834.
When was Ainos, Inc. formerly known as?
Ainos, Inc. was formerly known as Amarillo Biosciences Inc., with a name change date of May 16, 1996.
What is the fiscal year end for Ainos, Inc.?
The fiscal year end for Ainos, Inc. is December 31.
What is the business address of Ainos, Inc.?
The business address is 8880 Rio San Diego Drive, Suite 800, San Diego, CA 92108.
What is the SEC file number for Ainos, Inc.?
The SEC file number for Ainos, Inc. is 001-41461.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Ainos, Inc. (AIMDW).